Canadian Health Care Systems

Similar documents
How new vaccines are introduced into programs & why programs differ across Canada

HPV Immunization, Canadian Perspective

VACCINES FOR ADULTS. Developing an Underutilised Health Resource. 13 November 2007

The Federal Initiative To Address HIV/AIDS in Canada. Canada s Domestic Response to HIV/AIDS

Pandemic Influenza Planning Considerations in On-reserve First Nations Communities

Immunization Competencies Education Program

Appendix An Assessment Tool to Determine the Validity of Vaccine Doses

ANNEX B INFLUENZA PANDEMIC PLANNING CONSIDERATIONS IN ON RESERVE FIRST NATIONS COMMUNITIES

Monitoring of the achievement of the health-related Millennium Development Goals

Chapter 3: Roles and Responsibilities

A Report from the F/P/T Advisory Committee on Population Health and Health Security (ACPHHS) to the Conference of F/P/T Deputy Ministers of Health

Immunization Coverage Report for School Pupils in Ontario School Year

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014

Advocacy Strategy

Vaccine Decision-Making

Nova Scotia Diagnostic Imaging and Pathology & Laboratory Medicine (DIPLM) Initiative. Presentation to Atlantic Directors August 23, 2012

Fifth report of Committee A

Recommendations for Human Papillomavirus Vaccination Provincial Infectious Diseases Advisory Committee on Immunization

The G8 Dementia Summit: A Giant Step Forward for Dementia

Resolutions of the 50 th East, Central and Southern African Health Ministers Conference

CPhA PRE-BUDGET CONSULTATION BRIEF Prescriptions for a healthy and productive Canada

A1. Does your government have a formal, written diabetes policy or strategy?

The Canadian Strategy for Cancer Control: A Cancer Plan for Canada

An Investment in Public Health: An Investment in Canada s Future Prosperity

O N E R O O T, M A N Y R O U T E S Impact of User-Based System Design on Immunization Delivery

Brief. Ministry of Health and Long-Term Care. Health Based Allocation Model (HBAM) Funding Formula for LHINs. Mental Health & Addictions Sector

What are the new active vaccine recommendations in the Canadian Immunization Guide?

GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012

HEALTHY CANADIANS AND SUSTAINED ECONOMIC RECOVERY: PREDICTABLE VACCINE FUNDING IN CANADA

Introduction and overview of the program; new vaccine pipeline and prioritization process

3.04. Immunization. Chapter 3 Section. Background. Ministry of Health and Long-Term Care

Immunization Competencies Education Program

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

How does Gavi make vaccine investment decisions?

Changing the prevention paradigm for the future what Europe can do

Review of Controlled Drugs and Substances Act

What is to be done to respond to country needs and comply with WHA and SAGE recommendations?

The Sustainable Development Goals: The implications for health post Ties Boerma, Director of Information, Evidence and Research, WHO, Geneva

Human Papillomavirus (HPV) Vaccination Program Update

Strengthening Health Systems and Blood Services

Disclosure Statement. I have no affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization.

World Health Organization. A Sustainable Health Sector

Normalization and informed decision making in public health programs: A case study of HPV vaccination in Canada. Brenda Wilson Tanya Navaneelan

Thailand Expanded Program on Immunization. Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand

Background Paper for the OTDT Committees

Update of The National Vaccine Plan

Integrating Hepatitis Services into HIV Programs: Working Together to Meet Community Needs

Vaccine Safety: Its everyone s business! PHO Rounds: Nov 19, 2013

Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores

Chronic Non Communicable Disease. The Grenada Experience.

COMMUNICABLE DISEASE REPORT

Report to the Board 6-7 June 2018

POLICY AND ECONOMIC CONSIDERATIONS FOR FRAILTY SCREENING IN THE CANADIAN HEALTHCARE SYSTEM

Will the Canadian Government s Commitment to Use a Gender-based Analysis Result in Public Policies Reflecting the Diversity of Women s Lives?

Addressing Delay 2: Maternity Waiting Shelters to Improve Access to Services in Zambia

Measles Outbreak 2015 and Ontario's Immunization System

Lessons from the frontlines:

2018 AFP INTERNATIONAL COMMITTEE DESCRIPTIONS

ADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA

From Vaccine Development to Policy: A Brief Review of WHO Vaccine-Related Activities and Advisory Processes (2017)

7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids

Gavi initiatives for improving vaccine supply

Intensifying our efforts towards a world free of the avoidable burden of NCDs

ACIP Developing Vaccine Recommendations and Policy in the US

Building and Sustaining Political Commitment for Nutrition Action Lao PDR

CHAPTER 4: Population-level interventions

SCHOOL- BASED TYPHOID VACCINATION PROGRAM IN KARACHI: POLICY IMPLICATIONS FOR TYPHOID CONTROL

2018/ /21 SERVICE PLAN

BC First Nations Panorama Implementation Project (FN PIP) WE WOULD LIKE TO HEAR FROM YOU!

Gavi s Vaccine Investment Strategy

Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018

Gavi Alliance Strategy : Goal level indicators and disease dashboard

General Assembly. United Nations A/65/L.27. Global health and foreign policy. Distr.: Limited 1 December Original: English

AAP Immunization Initiatives JILL HERNANDEZ, MPH

Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C

Formal Reference Groups, Committees and Meetings

Evaluation of Immunization and Respiratory Infectious Disease Activities at the Public Health Agency of Canada to

THE GLOBAL STRATEGY FOR WOMEN S, CHILDREN S AND ADOLESCENTS HEALTH ( )

REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition

Ministry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference

STRATEGIC DIRECTIONS AND FUTURE ACTIONS: Healthy Aging and Continuing Care in Alberta

3. CONCLUSIONS AND RECOMMENDATIONS

Actions Taken and Future Directions 2011

PAEDIATRIC ASSOCIATION OF NIGERIA & CONTRIBUTIONS TO IMMUNIZATIONS IN NIGERIA

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030

OBSERVATIONS: WHO GLOBAL CONFERENCE ON NCDS PURSUING POLICY COHERENCE TO ACHIEVE SDG TARGET 3.4 ON NCDS (MONTEVIDEO, URUGUAY, OCTOBER 2017)

THE MULTI-SECTORAL APPROACH TO AIDS CONTROL IN UGANDA EXECUTIVE SUMMARY

Routine Immunization Schedules. Section 2. Newfoundland and Labrador Immunization Manual. Routine Immunization Schedules

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008

Program Priorities 2018

Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective

OPERATIONAL FRAMEWORK. for the Global Strategy for Women s, Children s and Adolescents Health

THE PMNCH 2012 REPORT ANALYSING PROGRESS ON COMMITMENTS TO THE GLOBAL STRATEGY FOR WOMEN S AND CHILDREN S HEALTH *****

Overview of M2K Policy Recommendations from Across Canada and Areas of Alignment

Countdown to 2015: tracking progress, fostering accountability

Cancer prevention and control in the context of an integrated approach

NACCHO COMMITTEES AND WORKGROUPS

The Human Papillomavirus Vaccine

Draft resolution submitted by the President of the General Assembly

Transcription:

Vaccine Decisions: Policy Making and Priority Setting in Canadian Health Care Systems Charlotte Moore Hepburn, MD, FRCPC, FAAP Lead, Child Health Policy Initiative Faculty Pediatrician, Division of Pediatric Medicine, The Hospital for Sick Children Assistant Professor, Department of Pediatrics, University of Toronto School of Medicine

Objectives Structure of Canadian health care system Processes supporting evidence-informed policy Challenges with evidence-informed policy-making Realities of priority setting in publicly-funded health care systems

Canada

The Greatest Canadian

Canadian Constitution VI. DISTRIBUTION OF LEGISLATIVE POWERS ARTICLE 91: o Powers of the Parliament ARTICLE 92: o Exclusive Powers of the Provincial Legislatures

Canada

Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial

Vaccine Decisions (2) Procurement Public Works and Government Services Canada (PWGSC) Federal Monitoring for Post-Market Vaccine Safety Health Canada (Biologics and Genetic Therapies Directorate) Federal Surveillance for Vaccine-Preventable Disease Ministriesof Health Provincial/Territorial Measuring Vaccine Coverage Ministries of Health Provincial/Territorial

Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial

Vaccine Decisions (2) Procurement Public Works and Government Services Canada (PWGSC) Federal Monitoring for Post-Market Vaccine Safety Health Canada (Biologics and Genetic Therapies Directorate) Federal Surveillance for Vaccine-Preventable Disease Ministriesof Health Provincial/Territorial Measuring Vaccine Coverage Ministries of Health Provincial/Territorial

Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial

Recommendations for Use National Advisory Committee on Immunization (NACI) Federal All-volunteer, scientific advisory committee o o Experts in pediatrics, infectious disease, immunology, medical microbiology, internal medicine, public health Serve in disease-specific working groups Supported by the Public Health Agency of Canada Approached by manufacturers, governments, scientific community Offer recommendations for the use of vaccines currently or newly approved for use in humans in Canada o Including definition of vaccine schedules, catch-up schedules, and identification of at-risk groups for whom vaccine programs should be targeted

Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Scientific Recommendations Only No economic analysis No policy or program delivery-related recommendations No funding-related decision-making authority Aims to: o Influence clinical activities (noting medial-legal implications) o Influence P/T jurisdictions

Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial

Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Federal/Provincial/Territorial delegate body o Experts in public health and public health policy Supported by the Public Health Network Council, reporting to the F/P/T Deputy Ministers of Health Provides policy and program recommendations related to the implementation of publicly funded vaccine programs

Structured Approach to Policy and Program Analysis 16

Erickson-DeWals Criteria Burden of Disease Outstanding Research Vaccine Questions Characteristics Equity Strategy Selection Ethical Considerations Cost-Effectiveness Legal Considerations Acceptability Program Conformity Feasibility Political Considerations Capacity to Evaluate

Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Science into Policy Recommendations Provide economic analysis Provide policy and program delivery-related recommendations No funding-related decision-making authority Aims to: o o o Reduce duplication of effort across P/T jurisdictions Influence decisions of P/T jurisdictions Promote harmonization of immunization schedules across the country

Science Science-Informed Policy Advice NACI CIC Federal, all-volunteer expert body Scientific recommendations with scheduled public release Moral Authority National, F/P/T delegate body Policy and program recommendations consistent with F/P/T norms Enabled Collaboration No resource-allocation decision-making No formal linkage to vaccine procurement process

Science Science-Informed Policy Advice 13 Different Vaccine Schedules 13 Different Procurement Strategies

Science Science-Informed Policy Advice 13 Different Vaccine Schedules 13 Different Procurement Strategies http://www.phac-aspc.gc.ca/im/ptimprog-progimpt/table-1-eng.php

Decisions regarding Public Funding Ministries of Health Provincial/Territorial Hepatitis B: Birth, 1 month, 6 months First introduced 1995 Hepatitis B: Grade 4 First introduced 1998 Hepatitis B (DtaP-HB-IPV-Hib): 2 months, 4 months, 6 months First introduced 1992

Decisions regarding Public Funding Ministries of Health Provincial/Territorial ): 12 months No Rotavirus Vaccine Program Oral Rotavirus Vaccine: 2 months, 4 months

Decisions regarding Public Funding Ministries of Health Provincial/Territorial NACI Recommendation: ): 2 months, 4 months, 6 months 12 July months 2010 Statement No Rotavirus Vaccine Program Oral Rotavirus Vaccine: 2 months, 4 months

Three Streams 1 Problem Policy Politics Kingdon, JW. (1995) Agendas, Alternatives and Public Policies. Longman, London.

Informing the Political Stream Evidence Platform Commitments Stakeholder Advocacy Legislative / Legal Imperative THE POLITICAL STREAM Resources Media Attention Public Expectations Time 1 1. Mitton, C et al. Difficult Decisions in Times of Constraint: Criteria based resource allocation in the Vancouver Coastal Health Authority. BMJ Health Services Research 2011; 11: 169

Three Streams 1 Problem NACI Policy CIC Politics Provincial Jurisdictions Kingdon, JW. (1995) Agendas, Alternatives and Public Policies. Longman, London.

Three Streams 1 Problem NACI Policy CIC Politics Provincial Jurisdictions WINDOW OF OPPORTUNITY Occasional, Sudden, Brief Kingdon, JW. (1995) Agendas, Alternatives and Public Policies. Longman, London.

Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial

Decisions regarding Public Funding Ministries of Health Provincial/Territorial Policy recommendations into policy Provincial / Territorial variation in o Burden of disease Differences in local epidemiology, populations and immigration patterns o Capacity to finance new vaccine programs Differences in provincial health priorities / pressures o Capacity to articulate policy case for new vaccine investment Differences in public health / health policy processes and resources o Capacity to implement new vaccine program Differences in vaccine delivery models Informed by P/T-level Vaccine Advisory Bodies (i.e. PIDAC)

Decisions regarding Public Funding Ministries of Health Provincial/Territorial Policy recommendations into policy Variation in o Burden of disease Differences in local epidemiology, populations and immigration patterns o Capacity to finance new vaccine programs Differences in provincial health priorities / pressures o Capacity to articulate policy case for new vaccine investment Differences in public health / health policy processes and resources o Capacity to implement new vaccine program Differences in vaccine delivery models

Willie Sutton School of Public Policy Safe, Effective and Cost Effective = Necessary Not Sufficient

Decisions regarding Public Funding Ministries of Health Provincial/Territorial ): 12 months Funded HPV Vaccination Programs

Priority Setting in Publicly Funded Health Systems New Vaccine Programs Capital Enhancements for Public Health Laboratories Enhanced Communicable Disease Surveillance Public Heath Priority Innovative Chronic Disease Prevention Programming Enhanced Breastfeeding Supports and Services Increased Food and Water Safety Protection Officers

Priority Setting in Publicly Funded Health Systems New Vaccine Programs Expansion of Newborn Screening Services Child Heath System Priority Funding for Double Cochlear Implants Investment in School- Based Mental Health Services Improved Access to Level III NICU Care

Priority Setting in Publicly Funded Health Systems New Vaccine Programs Expansion of Telemedicine Services to Remote Communities Heath System Priority Improved Access to Level III NICU Care Investment in System- Wide Electronic Health Records Reduced Wait Times for Joint Replacement Surgery

Priority Setting in Publicly Funded Health Systems New Vaccine Programs Expansion of Telemedicine Services to Remote Communities Heath System Priority Improved Access to Level III NICU Care Investment in System- Wide Electronic Health Records Reduced Wait Times for Joint Replacement Surgery

Priority Setting in Publicly Funded Health Systems New Vaccine Programs Creation of Affordable Public Housing System Priority Smaller Elementary School Class Sizes Investments in critical elements of transportation infrastructure New Job Training Programs for Seasonal Workers

Favorable Vaccine Environments Prosperous economic conditions Opportunity for secondary economic gain Well organized political support o Industry Lobby o Public Health Lobby * o Provincial Medical Associations * o Child Health Advocates Aligned political commitments / priorities o Easily executed health promotion / disease prevention promises Leading cross-jurisdictional comparators Receptive public Compelling policy narrative

Vaccine Decisions (2) Procurement Public Works and Government Services Canada (PWGSC) Federal Monitoring for Post-Market Vaccine Safety Health Canada (Biologics and Genetic Therapies Directorate) Federal Surveillance for Vaccine-Preventable Disease Ministriesof Health Provincial/Territorial Measuring Vaccine Coverage Ministries of Health Provincial Territorial

Measuring Vaccine Coverage Ministries of Health Provincial/Territorial 13 systems to measure vaccine coverage o Varied delivery systems o Varied IT capacity o Varied requirements regarding vaccine coverage reporting o Varied province-level health services research infrastructure New horizon = PANORAMA o Common data definitions o National-level public health data collection (partial participation)* Opportunity for important health services research o Need to discern differences in outcomes across jurisdictions

Objectives Structure of Canadian health care system Processes supporting evidence-informed policy Challenges with evidence-informed policy-making Realities of priority setting in publicly-funded health care systems